Escamilla Gómez, Virginia <br/><br/>
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.  [electronic resource] 

 -  Bone marrow transplantation  03 2020 
 - 641-648 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5365 
<br/><br/><label>Standard No.: </label>10.1038/s41409-019-0731-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Chronic Disease<br/>Graft vs Host Disease--drug therapy<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Nitriles<br/>Pyrazoles--therapeutic use<br/>Pyrimidines<br/>Retrospective Studies